The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?

Christopher J. Rhodes

Source: Eur Respir J, 56 (5) 2002350; 10.1183/13993003.02350-2020

Journal Issue: November

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christopher J. Rhodes. The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?. Eur Respir J, 56 (5) 2002350; 10.1183/13993003.02350-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Is there an obesity paradox in pulmonary arterial hypertension? Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017
Pathogenesis of pulmonary arterial hypertension: lessons from cancer Source: Eur Respir Rev 2013; 22: 543-551 Year: 2013
Challenging the concept of adding more drugs in pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017 Year: 2017
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target Source: Eur Respir J 2011; 38: 1453-1460 Year: 2011
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015
The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019
Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that? Source: Eur Respir J, 50 (1) 1701191; 10.1183/13993003.01191-2017 Year: 2017
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives Source: Eur Respir Rev 2016; 25: 135-140 Year: 2016
The revolution of pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 361-363 Year: 2016
The genetics of pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010
When is pulmonary hypertension not pulmonary hypertension? Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better? Source: Eur Respir J 2006 Oct 01;28(4):683-686 Year: 2006
The new definition of pulmonary hypertension Source: Eur Respir J 2009; 34: 790-791 Year: 2009
Novel treatment for pulmonary vascular disease: lessons from pathophysiology Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006
CC6 Is it truly pulmonary arterial hypertension? Source: Milan 2017 - Educational material Year: 2017
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension Source: Eur Respir Rev, 30 (162) 210161; 10.1183/16000617.0161-2021 Year: 2021
Is the increase in NO lung transfer due to free plasmatic hemoglobin in pulmonary arterial hypertension? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Autoimmunity and pulmonary arterial hypertension: The role of leptin Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011
Contribution of stem-like cells to angioproliferative pulmonary arterial hypertension in the SU5416/chronic hypoxia model Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012